摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

10-(4-Cyclohex-1-en-1-yl-3-methylbenzoyl)-N-[((4S,5S)-5-{(R)-hydroxy[(4R)-2-oxo-1,3-dioxolan-4-yl]methyl}-2-oxo-1,3-dioxolan-4-yl)methyl]-N-methyl-10,11-dihydro-5H-pyrrolo [2,1-c][1,4] benzodiazepine-3-carboxamide | 473665-62-2

中文名称
——
中文别名
——
英文名称
10-(4-Cyclohex-1-en-1-yl-3-methylbenzoyl)-N-[((4S,5S)-5-{(R)-hydroxy[(4R)-2-oxo-1,3-dioxolan-4-yl]methyl}-2-oxo-1,3-dioxolan-4-yl)methyl]-N-methyl-10,11-dihydro-5H-pyrrolo [2,1-c][1,4] benzodiazepine-3-carboxamide
英文别名
5-[4-(cyclohexen-1-yl)-3-methylbenzoyl]-N-[[(4S,5S)-5-[(R)-hydroxy-[(4R)-2-oxo-1,3-dioxolan-4-yl]methyl]-2-oxo-1,3-dioxolan-4-yl]methyl]-N-methyl-6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-9-carboxamide
10-(4-Cyclohex-1-en-1-yl-3-methylbenzoyl)-N-[((4S,5S)-5-{(R)-hydroxy[(4R)-2-oxo-1,3-dioxolan-4-yl]methyl}-2-oxo-1,3-dioxolan-4-yl)methyl]-N-methyl-10,11-dihydro-5H-pyrrolo [2,1-c][1,4] benzodiazepine-3-carboxamide化学式
CAS
473665-62-2
化学式
C36H37N3O9
mdl
——
分子量
655.704
InChiKey
XLGDURXXCSKWLQ-SYEZAVJTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    48
  • 可旋转键数:
    7
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    137
  • 氢给体数:
    1
  • 氢受体数:
    9

文献信息

  • EP1385849A1
    申请人:——
    公开号:EP1385849A1
    公开(公告)日:2004-02-04
  • US6977254B2
    申请人:——
    公开号:US6977254B2
    公开(公告)日:2005-12-20
  • [EN] NOVEL HYDROXY CYCLOHEXENYL PHENYL CARBOXAMIDES TOCOLYTIC OXYTOCIN RECEPTOR ANTAGONISTS<br/>[FR] NOUVEAUX HYDROXY-CYCLOHEXENYL-PHENYL-CARBOXAMIDES ANTAGONISTES TOCOLYTIQUES DU RECEPTEUR DE L'OCYTOCINE
    申请人:WYETH CORP
    公开号:WO2002083679A1
    公开(公告)日:2002-10-24
    The present invention provides substituted 10, 11-Dihydro-5H-benzo[e]-pyrrolo-[1,2-a][1,4]diazepine and 9,10-Dihydro-4H-3a,5,9-triaza-benzo[f]azulene compounds as well as methods and pharmaceutical compositions utilizing these compounds for the treatment and/or prevention and/or supression of disorders which may be remedied or alleviated by oxytocin antagonist activity, including prevention and/or suppression of preterm labor, suppression labor at term prior to caesarean deliver, and for the treatmet of dysmenorrhea. These compounds are also useful in enhancing fertility rates, enhancing survival rates and synchronizing estrus in farm animals.
查看更多